Cargando…

Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been associated with several neurological disorders including headache, facial palsy, encephalitis, stroke, demyelinating disorders. The present report will discuss cases of multiple sclerosis (MS) onset and relapse both begi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pignolo, Antonia, Aprile, Maria, Gagliardo, Cesare, Giammanco, Giovanni Maurizio, D’Amelio, Marco, Aridon, Paolo, La Tona, Giuseppe, Salemi, Giuseppe, Ragonese, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707620/ https://www.ncbi.nlm.nih.gov/pubmed/34940752 http://dx.doi.org/10.3390/neurolint13040066

Ejemplares similares

Case series: Multiple sclerosis clinical onset and relapse after SARS-CoV-2 Infection
por: Pignolo, Antonia, et al.
Publicado: (2021)

Microchimerism in multiple sclerosis: The association between sex of offspring and MRI features in women with multiple sclerosis
por: Bianchi, Alessia, et al.
Publicado: (2023)

Stroke incidence and case fatality: a 9-year prospective population-based study in an elderly population of Bagheria, Italy
por: Arnao, Valentina, et al.
Publicado: (2020)

Vitamin D and Parkinson’s Disease
por: Pignolo, Antonia, et al.
Publicado: (2022)

Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study
por: Ragonese, Paolo, et al.
Publicado: (2017)

COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection
por: Iacono, Salvatore, et al.
Publicado: (2023)

A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?
por: Schirò, Giuseppe, et al.
Publicado: (2022)

Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke: Posterior ischemic stroke and hemorrhagic transformation
por: Valentino, Francesca, et al.
Publicado: (2017)

Evaluation of serum and cerebrospinal fluid biomarkers after vaccination against SARS‐CoV‐2
por: Iacono, Salvatore, et al.
Publicado: (2023)

The Role of Nutritional Lifestyle and Physical Activity in Multiple Sclerosis Pathogenesis and Management: A Narrative Review
por: Fanara, Salvatore, et al.
Publicado: (2021)

Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound with a 1.5 Tesla Scanner: A Prospective Intraindividual Comparison Study of Intraoperative Imaging
por: Gagliardo, Cesare, et al.
Publicado: (2021)

Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid
por: Geraci, Fabiana, et al.
Publicado: (2018)

Preoperative imaging findings in patients undergoing transcranial magnetic resonance imaging-guided focused ultrasound thalamotomy
por: Gagliardo, Cesare, et al.
Publicado: (2021)

Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients
por: Bianchi, Alessia, et al.
Publicado: (2020)

Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment
por: Valentino, Francesca, et al.
Publicado: (2018)

Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach
por: Colomba, Paolo, et al.
Publicado: (2014)

Lactate Threshold Training Program on Patients with Multiple Sclerosis: A Multidisciplinary Approach
por: Amato, Alessandra, et al.
Publicado: (2021)

Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients
por: Salemi, Giuseppe, et al.
Publicado: (2010)

Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers
por: Lo Re, Marianna, et al.
Publicado: (2015)

Malignancy course of pituitary adenoma in MEN1 syndrome: Clinical-Neuroradiological signs
por: Incandela, Francesca, et al.
Publicado: (2020)

Role of Multiple Vitamin D-Related Polymorphisms in Multiple Sclerosis Severity: Preliminary Findings
por: Agnello, Luisa, et al.
Publicado: (2022)

Klotho and vitamin D in multiple sclerosis: an Italian study
por: Scazzone, Concetta, et al.
Publicado: (2019)

Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
por: D’Amico, Emanuele, et al.
Publicado: (2018)

Impaired circadian heart rate variability in Parkinson’s disease: a time-domain analysis in ambulatory setting
por: Arnao, V., et al.
Publicado: (2020)

Early red nucleus atrophy in relapse‐onset multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2020)

Gazing at Social Interactions Between Foraging and Decision Theory
por: D'Amelio, Alessandro, et al.
Publicado: (2021)

FOXP3 and GATA3 Polymorphisms, Vitamin D3 and Multiple Sclerosis
por: Scazzone, Concetta, et al.
Publicado: (2021)

Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis
por: Hedström, Anna Karin, et al.
Publicado: (2021)

Comorbid substance abuse and brain morphology in recent-onset psychosis
por: Wobrock, Thomas, et al.
Publicado: (2009)

Radiomics and Prostate MRI: Current Role and Future Applications
por: Cutaia, Giuseppe, et al.
Publicado: (2021)

Mercaptopurine Treatment in an Adult Man with Orbital and Intracranial Rosai-Dorfman Disease
por: Arnao, Valentina, et al.
Publicado: (2016)

Quantitative T1 mapping detects blood–brain barrier breakdown in apparently non-enhancing multiple sclerosis lesions
por: Donatelli, Graziella, et al.
Publicado: (2023)

Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic
por: Margoni, Monica, et al.
Publicado: (2020)

Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2021)

Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis
por: Barkhof, Frederik, et al.
Publicado: (2019)

Male Osteoporosis in the Elderly
por: D'Amelio, Patrizia, et al.
Publicado: (2015)

Corrigendum to “Male Osteoporosis in the Elderly”
por: D'Amelio, Patrizia, et al.
Publicado: (2017)

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
por: Coret, Francisco, et al.
Publicado: (2018)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
por: Feraco, Paola, et al.
Publicado: (2021)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g9ukit502snjv6oaru91tgk68l